Go to main content. Press Shift+? for keyboard-shortcuts.

CyPass® Micro-Stent Market Withdrawal

Information and resources for healthcare professionals

Patients implanted with a CyPass® Micro-Stent are encouraged to contact their eye doctor to schedule an in-office evaluation.  Media inquiries should be directed to Steven Smith at +1 817 551 8211 or steven_p.smith@alcon.com.

Information from Alcon

ESCRS Scientific Presentation / Sept. 24, 2018
Overview of the results from the 5 year follow up study of the CyPass® Micro-Stent
Read More

Dear Healthcare Professional Letter / Aug. 29, 2018
Voluntary Medical Device Market Withdrawal Notification
Read More

Alcon Media Release / Aug. 29, 2018
Alcon announces voluntary global market withdrawal of CyPass® Micro-Stent for surgical glaucoma
Read More

Product Information
CyPass® Ultra System Instructions for Use
Read More

Product Information
CyPass® Micro-Stent Instructions for Use
Read More 

Other Resources

The following information has been published by other professional and regulatory organizations, and is provided as a service to healthcare professionals. Alcon assumes no responsibility for the information provided by these independent organizations.

FDA Safety Communication / Oct. 24, 2018
UPDATE: Potential Eye Damage from Alcon CyPass Micro-Stent Used to Treat Open-Angle Glaucoma: FDA Safety Communication
Read More

ASCRS Statement / Sept. 25, 2018
Preliminary ASCRS CyPass Withdrawal Consensus Statement
Read More

FDA Safety Communication / Sept. 14, 2018
Potential Eye Damage From Alcon CyPass Micro-Stent Used to Treat Open-Angle Glaucoma
Read More

Contact Information for U. S. Customers

Customer Services - for assistance with product returns
+1 800 862 5266

Medical Information - for medical information on the CyPass Micro-Stent
+1 800 757 9785

Medical Safety - to report product complaints or adverse events
+1 800 757 9780

Customers located outside the U.S. should contact their local Alcon representative.